home / stock / sny / sny news


SNY News and Press, Sanofi From 05/31/24

Stock Information

Company Name: Sanofi
Stock Symbol: SNY
Market: NASDAQ
Website: sanofi.com

Menu

SNY SNY Quote SNY Short SNY News SNY Articles SNY Message Board
Get SNY Alerts

News, Short Squeeze, Breakout and More Instantly...

SNY - Regeneron/ Sanofi say FDA has delayed Dupixent COPD label

2024-05-31 06:49:06 ET More on Sanofi, Regeneron, etc. Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript) Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks Regeneron Pharmaceuticals, Inc. (REGN) Q1...

SNY - Third human bird flu case found in U.S.

2024-05-30 13:46:56 ET More on CureVac, GSK, etc. GSK plc: Long-Term Cash Cow Pfizer: The Chart Looks Like A Bottom, But Is The Dividend Safe? Pfizer: Turning The Corner (Rating Upgrade) Moderna nearing deal to win U.S. funding for bird flu vaccine trial: FT ...

SNY - Moderna nearing deal to win U.S. funding for bird flu vaccine trial: FT

2024-05-30 07:04:27 ET More on Moderna Moderna: Betting On Bird Flu Rally Is A Poor Strategy For A Value Investor Aggressive Strides Forward For Moderna's Cancer Vaccine Moderna Q1: A Promising Pipeline Is Undervalued Moderna down ~9%, likely ending 10-sessio...

SNY - Sanofi's Sarclisa gets accepted for FDA priority review for treatment of multiple myeloma

2024-05-27 02:50:31 ET More on Sanofi Sanofi Q1: Wait And See For Now (Downgrade) Sanofi: Q1 Earnings Reflect Growth And Strategic Acquisitions (Rating Upgrade) Sanofi says asthma candidate rilzabrutinib buoyed by phase 2 results Bristol-Myers, Sanofi liabili...

SNY - Unloved Gilead Due For Reversal On Flight-To-Safety Money Flows

2024-05-27 01:45:30 ET Summary Gilead is sitting at one of the lowest valuations in the Big Pharma sector, with a high and sustainable 4.6% dividend yield available for new buyers. The stock has an enviable track record of rising strongly in price when turmoil hits Wall Street and...

SNY - Catalyst Watch: Costco earnings, M&A drama, Viking ratings, and a key inflation read

2024-05-24 15:00:53 ET More on the markets S&P 500: It Is All About Liquidity SPY: Time To Be Contrarian And Underweight SPY ETF: Momentum Is In The Cards Stocks have more room to run - Invesco's Kristina Hooper Big bear Mike Wilson changes tune a...

SNY - Dodge & Cox International Stock Fund Q1 2024 Shareholder Letter

2024-05-24 10:00:00 ET Summary Dodge & Cox Stock Fund seeks long-term growth of principal and income, with a secondary focus on achieving a reasonable current income. During the first quarter of 2024, international equities performed well, especially in developed markets....

SNY - Dodge & Cox Global Stock Fund Q1 2024 Shareholder Letter

2024-05-24 07:00:00 ET Summary Dodge & Cox Stock Fund seeks long-term growth of principal and income, with a secondary focus on achieving a reasonable current income. Global equity markets achieved all-time highs during the first quarter of 2024, with the MSCI ACWI up 8.2...

SNY - Dodge & Cox Stock Fund Q1 2024 Shareholder Letter

2024-05-24 06:05:00 ET Summary Dodge & Cox Stock Fund seeks long-term growth of principal and income, with a secondary focus on achieving a reasonable current income. U.S. equity markets rose to all-time highs during the first quarter of 2024, extending the robust perform...

SNY - Pfizer, Moderna in talks with HHS over avian flu vaccine: report

2024-05-22 18:09:14 ET More on Moderna, Pfizer, etc. The Prognosis For Pfizer Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs Aggressive Strides Forward For Moderna's Cancer Vaccine Moderna, BioNTech close with double-digit perc...

Previous 10 Next 10